Mavacamten will lower the level or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may lower systemic exposures of ethinyl estradiol and progestin, which can result in contraceptive failure or an increase in breakthrough https://barbarah914tur0.muzwiki.com/user